Kopetz S - Search Results

1

Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer.

Dienstmann R, Vermeulen L, Guinney J, Kopetz S, Tejpar S, Tabernero J. Dienstmann R, et al. Among authors: kopetz s. Nat Rev Cancer. 2017 Feb;17(2):79-92. doi: 10.1038/nrc.2016.126. Epub 2017 Jan 4. Nat Rev Cancer. 2017. PMID: 28050011 Review.

2

The SRC family of protein tyrosine kinases: a new and promising target for colorectal cancer therapy.

Lieu C, Kopetz S. Lieu C, et al. Among authors: kopetz s. Clin Colorectal Cancer. 2010 Apr;9(2):89-94. doi: 10.3816/CCC.2010.n.012. Clin Colorectal Cancer. 2010. PMID: 20378502 Free PMC article. Review.

3

PI-3-Kinase inhibitors in colorectal cancer.

Ihle NT, Powis G, Kopetz S. Ihle NT, et al. Among authors: kopetz s. Curr Cancer Drug Targets. 2011 Feb;11(2):190-8. doi: 10.2174/156800911794328448. Curr Cancer Drug Targets. 2011. PMID: 21158718 Review.

4

"Right drug for the right patient": hurdles and the path forward in colorectal cancer.

Kopetz S. Kopetz S. Am Soc Clin Oncol Educ Book. 2013. doi: 10.14694/EdBook_AM.2013.33.e115. Am Soc Clin Oncol Educ Book. 2013. PMID: 23714474 Free article. Review.

5

Clinical biomarkers in colorectal cancer.

Morris V, Kopetz S. Morris V, et al. Among authors: kopetz s. Clin Adv Hematol Oncol. 2013 Dec;11(12):768-76. Clin Adv Hematol Oncol. 2013. PMID: 24893280 Review.

6

Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program.

Lieu CH, Renfro LA, de Gramont A, Meyers JP, Maughan TS, Seymour MT, Saltz L, Goldberg RM, Sargent DJ, Eckhardt SG, Eng C; Aide et Recherche en Cancérologie Digestive Foundation. Lieu CH, et al. J Clin Oncol. 2014 Sep 20;32(27):2975-84. doi: 10.1200/JCO.2013.54.9329. J Clin Oncol. 2014. PMID: 25002720 Free PMC article.

7

Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors.

Kopetz S, Tabernero J, Rosenberg R, Jiang ZQ, Moreno V, Bachleitner-Hofmann T, Lanza G, Stork-Sloots L, Maru D, Simon I, Capellà G, Salazar R. Kopetz S, et al. Oncologist. 2015 Feb;20(2):127-33. doi: 10.1634/theoncologist.2014-0325. Epub 2015 Jan 5. Oncologist. 2015. PMID: 25561511 Free PMC article.

8

Current and Future Approaches to Target the Epidermal Growth Factor Receptor and Its Downstream Signaling in Metastatic Colorectal Cancer.

Lee MS, Kopetz S. Lee MS, et al. Among authors: kopetz s. Clin Colorectal Cancer. 2015 Dec;14(4):203-18. doi: 10.1016/j.clcc.2015.05.006. Epub 2015 May 29. Clin Colorectal Cancer. 2015. PMID: 26077270 Review.

9

Extended RAS analysis for anti-epidermal growth factor therapy in patients with metastatic colorectal cancer.

Hecht JR, Douillard JY, Schwartzberg L, Grothey A, Kopetz S, Rong A, Oliner KS, Sidhu R. Hecht JR, et al. Among authors: kopetz s. Cancer Treat Rev. 2015 Sep;41(8):653-9. doi: 10.1016/j.ctrv.2015.05.008. Epub 2015 May 21. Cancer Treat Rev. 2015. PMID: 26220150 Free article. Review.

10

The consensus molecular subtypes of colorectal cancer.

Guinney J, Dienstmann R, Wang X, de Reyniès A, Schlicker A, Soneson C, Marisa L, Roepman P, Nyamundanda G, Angelino P, Bot BM, Morris JS, Simon IM, Gerster S, Fessler E, De Sousa E Melo F, Missiaglia E, Ramay H, Barras D, Homicsko K, Maru D, Manyam GC, Broom B, Boige V, Perez-Villamil B, Laderas T, Salazar R, Gray JW, Hanahan D, Tabernero J, Bernards R, Friend SH, Laurent-Puig P, Medema JP, Sadanandam A, Wessels L, Delorenzi M, Kopetz S, Vermeulen L, Tejpar S. Guinney J, et al. Among authors: kopetz s. Nat Med. 2015 Nov;21(11):1350-6. doi: 10.1038/nm.3967. Epub 2015 Oct 12. Nat Med. 2015. PMID: 26457759 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

444 results

Search Page